Product Information

SUMATRIPTAN 6 MG/0.5 ML AUTOINJ is a generic product labeled by NorthStar Rx LLC, priced at $57.0902 per ML under NDC 72603014102. Its NADAC has been published 163 times since Oct 11, 2023.

FDA first approved this application on Jan 29, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SUMATRIPTAN 6 MG/0.5 ML AUTOINJ

Sumatriptan Succinate
$57.0902per ML

Strength

6 mg/.5mL

Manufacturer

NorthStar Rx LLC

NDC

72603014102

Classification

Generic

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Effective Date

11/18/2026

Active Ingredients

SUMATRIPTAN SUCCINATE

Approval Type

Generic (ANDA)

FDA Application

ANDA090495

FDA Approved

1/29/2014

TE Code

AB

On Market Since

6/13/2023

Pharmacological Classes

Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist

Price Statistics

The NADAC for SUMATRIPTAN 6 MG/0.5 ML AUTOINJ has been published 163 times since Oct 11, 2023, and over the history we have for it it has declined 14.3%. The table below summarizes its recorded NADAC range and movement.

Current price$57.0902 per ML
All-time high$88.4883 (Oct 16, 2024)
All-time low$46.6942 (May 22, 2024)
52-week high$75.8160
52-week low$57.0902
Median price$69.1026
Average price$67.0197
Largest weekly change+61.1% (Jun 19, 2024)
Weeks tracked163
Tracking sinceOct 11, 2023

Price History

1W

-3.9%

1M

-7.0%

3M

-7.5%

6M

-17.9%

1Y

-23.1%

3Y

-10.4%

5Y

N/A

All

-14.3%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 74% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SUMATRIPTAN 6 MG/0.5 ML AUTOINJ?

The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN 6 MG/0.5 ML AUTOINJ, manufactured by NorthStar Rx LLC, is $57.0902 per ML (NDC 72603014102), effective Nov 18, 2026.

How has the price of SUMATRIPTAN 6 MG/0.5 ML AUTOINJ changed over time?

Over the history we have for it, the NADAC for SUMATRIPTAN 6 MG/0.5 ML AUTOINJ has declined 14.3%. It has been tracked across 163 weekly CMS publications since Oct 11, 2023.

What are the highest and lowest recorded NADAC prices for SUMATRIPTAN 6 MG/0.5 ML AUTOINJ?

Since Oct 11, 2023, the NADAC for SUMATRIPTAN 6 MG/0.5 ML AUTOINJ has ranged from a low of $46.6942 (May 22, 2024) to a high of $88.4883 (Oct 16, 2024), with a median of $69.1026 per ML.

Are there cheaper alternatives to SUMATRIPTAN 6 MG/0.5 ML AUTOINJ?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SUMATRIPTAN 6 MG/0.5 ML VIAL, is $15.0000 per ML — about 74% below SUMATRIPTAN 6 MG/0.5 ML AUTOINJ.

Who manufactures SUMATRIPTAN 6 MG/0.5 ML AUTOINJ?

SUMATRIPTAN 6 MG/0.5 ML AUTOINJ (NDC 72603014102) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.